Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Genomics England progresses

Country: United Kingdom

Genomics England has taken the next step towards sequencing the genomes of a large number of patients in the National Health Service (NHS) with the appointment of industry partners to help it explore the potential of liquid biopsy tests to manage cancer.

Read more

Roche sees further growth

Country: Switzerland

The Roche group expects to see core earnings per share grow in line with a mid-single digit percentage rise in sales this year on the back of a steady increase in demand for its legacy and new pharmaceutical products. The US remains a key market for the Swiss multinational.

Read more

Second gene therapy approved

Read more

Roche commits to antibiotics

Country: United States

Read more

Sales of antibiotic drugs for animals drop

Country: United Kingdom

Read more

FDA committee recommends Spark’s gene therapy

Country: United States

Read more

Erytech proposes $100 million offering

Country: France

Read more

Kiadis raises €18 million in placement

Country: Netherlands

Read more

Faron share placement is fully subscribed

Country: Finland

Read more

EMA relocation to be decided on 20 November

Country: United Kingdom

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

How artificial intelligence is changing drug discovery

ArtificialintelligenceSept2017.pdf

Highlights of the September 2017 MedNous issue

The September 2017 MedNous features:

Latest Mednous cover
  • Business Strategy
    How artificial intelligence
    is changing drug discovery
  • Research Strategy
    Novel immunotherapy arises from collaboration
    By Andrea van Elsas
  • Oncology Review
    Long-term strategies for immuno-oncology
    By Bruno Pagliara
  • MedNous Briefing
    EU examines incentives for the pharma industry
    By Jane Morrison
  • Stock Market Commentary
    A phenotypic share analysis
    By William Ellington

The latest MedNous journal. Subscribe to download.

Recent Appointments